Immunologic defects in 22q11.2 deletion syndrome

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 2, 2008, Pages

  McLean Tooke, Andrew ^a   Barge, Dawn ^a   Spickett, Gavin P ^a   Gennery, Andrew R ^b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

22q11.2 Deletion syndrome; autoimmunity; DiGeorge syndrome; lymphocyte count; memory B cells; regulatory T cells

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL COUNT; CELLULAR IMMUNITY; CHROMOSOME 22Q; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTE; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; THYMUS;

EID: 48349130692     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.03.033     Document Type: Article

References (40)

1. Kobrynski L.J., and Sullivan K.E. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370 (2007) 1443-1452
2. Devriendt K., Fryns J.P., Mortier G., van Thienen M.N., and Keymolen K. The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 35 (1998) 789-790
3. Goodship J., Cross I., LiLing J., and Wren C. A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 79 (1998) 348-351
4. Sullivan K.E., Jawad A.F., Randall P., Driscoll D.A., Emanuel B.S., McDonald-McGinn D.M., et al. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clin Immunol Immunopathol 86 (1998) 141-146
5. Perez E., and Sullivan K.E. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr 14 (2002) 678-683
6. Sediva A., Bartunkova J., Zachova R., Polouckova A., Hrusak O., Janda A., et al. Early development of immunity in DiGeorge syndrome. Med Sci Monit 11 (2005) 182-187
7. Junker A.K., and Driscoll D.A. Humoral immunity in DiGeorge syndrome. J Pediatr 127 (1995) 231-237
8. Smith C.A., Driscoll D.A., Emanuel B.S., McDonald-McGinn D.M., Zackai E.H., and Sullivan K.E. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 5 (1998) 415-417
9. Gennery A.R., Barge D., O'Sullivan J.J., Flood T.J., Abinun M., and Cant A.J. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86 (2002) 422-425
10. Jawad A.F., McDonald-Mcginn D.M., Zackai E., and Sullivan K.E. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr 139 (2001) 715-723
11. Finocchi A., Di Cesare S., Romiti M.L., Capponi C., Rossi P., Carsetti R., et al. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatr Allergy Immunol 17 (2006) 382-388
12. Chinen J., Rosenblatt H.M., Smith E.O., Shearer W.T., and Noroski L.M. Long-term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol 111 (2003) 573-579
13. Lavi R.F., Kamchaisatian W., Sleasman J.W., Martin D.P., Haraguchi S., Day N.K., et al. Thymic output markers indicate immune dysfunction in DiGeorge syndrome. J Allergy Clin Immunol 118 (2006) 1184-1186
14. Sakamoto O., Imaizumi M., Suzuki A., Sato A., Tanaka T., Ogawa E., et al. Refractory autoimmune hemolytic anemia in a patient with chromosome 22q11.2 deletion syndrome. Pediatr Int 46 (2004) 612-614
15. Sullivan K.E., McDonald-McGinn D.M., Driscoll D.A., Zmijewski C.M., Ellabban A.S., Reed L., et al. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum 40 (1997) 430-436
16. Brown J.J., Datta V., Browning M.J., and Swift P.G. Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion. J Pediatr Endocrinol Metab 17 (2004) 1575-1579
17. Ziegler S.F. FOXP3: of mice and men. Annu Rev Immunol 24 (2006) 209-226
18. Dejaco C., Duftner C., Grubeck-Loebenstein B., and Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117 (2006) 289-300
19. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184 (1996) 387-396
20. Sullivan K.E., McDonald-McGinn D., and Zackai E.H. CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. Clin Diagn Lab Immunol 9 (2002) 1129-1131
21. McLean-Tooke A., Barge D., Spickett G.P., and Gennery A.R. T cell receptor VBeta repertoire of T lymphocytes and T regulatory cells by flow cytometric analysis in healthy children. Clin Exp Immunol 151 (2008) 190-198
22. Sempowski G.D., Hicks C.B., Eron J.J., Bartlett J.A., Hale L.P., Ferrari G., et al. Naive T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function. J Clin Immunol 25 (2005) 462-472
23. Kimmig S., Przybylski G.K., Schmidt C.A., Laurisch K., Mowes B., Radbruch A., et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 195 (2002) 789-794
24. Junge S., Kloeckener-Gruissem B., Zufferey R., Keisker A., Salgo B., Fauchere J.C., et al. Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. Eur J Immunol 37 (2007) 3270-3280
25. Klein U., Rajewsky K., and Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 188 (1998) 1679-1689
26. Shi Y., Agematsu K., Ochs H.D., and Sugane K. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin Immunol 108 (2003) 128-137
27. Kanaya Y., Ohga S., Ikeda K., Furuno K., Ohno T., Takada H., et al. Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome. Clin Exp Immunol 144 (2006) 85-93
28. Xiong N., and Raulet D.H. Development and selection of gammadelta T cells. Immunol Rev 215 (2007) 15-31
29. Piliero L.M., Sanford A.N., McDonald-McGinn D.M., Zackai E.H., and Sullivan K.E. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 103 (2004) 1020-1025
30. Murray J.M., Kaufmann G.R., Hodgkin P.D., Lewin S.R., Kelleher A.D., Davenport M.P., et al. Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty. Immunol Cell Biol 81 (2003) 487-495
31. Steffens C.M., Al-Harthi L., Shott S., Yogev R., and Landay A. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naive phenotypes. Clin Immunol 97 (2000) 95-101
32. Jameson S.C. T cell homeostasis: keeping useful T cells alive and live T cells useful. Semin Immunol 17 (2005) 231-237
33. Bourgeois C., and Stockinger B. T cell homeostasis in steady state and lymphopenic conditions. Immunol Lett 107 (2006) 89-92
34. Holmes S., He M., Xu T., and Lee P.P. Memory T cells have gene expression patterns intermediate between naive and effector. Proc Natl Acad Sci U S A 102 (2005) 5519-5523
35. Liston A., and Rudensky A.Y. Thymic development and peripheral homeostasis of regulatory T cells. Curr Opin Immunol 19 (2007) 176-185
36. Pillai V., and Karandikar N.J. Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation?. Immunol Lett 114 (2007) 9-15
37. Vukmanovic-Stejic M., Zhang Y., Cook J.E., Fletcher J.M., McQuaid A., Masters J.E., et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116 (2006) 2423-2433
38. Kung S.J., Gripp K.W., Stephan M.J., Fairchok M.P., and McGeady S.J. Selective IgM deficiency and 22q11.2 deletion syndrome. Ann Allergy Asthma Immunol 99 (2007) 87-92
39. Al-Herz W., McGeady S.J., and Gripp K.W. 22q11.2 deletion syndrome and selective IgM deficiency: an association of a common chromosomal abnormality with a rare immunodeficiency. Am J Med Genet A 127 (2004) 99-100
40. Vos Q., Lees A., Wu Z.Q., Snapper C.M., and Mond J.J. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176 (2000) 154-170